Market Place
Sourcing Support
Spyglass Pharma Reveals Positive Glaucoma Therapy Trial Results
14 Nov 2025 //
INDPHARMAPOST
Spyglass Pharma Reports Positive 36-Month Human Trial Results
10 Nov 2025 //
GLOBENEWSWIRE
Spyglass Pharma`s BIM-IOL System Shows Significant Mean IOP
14 Oct 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Names Anand Sundaram as Commercial Head
16 Sep 2025 //
GLOBENEWSWIRE
Elizabeth O’Farrell Joins SpyGlass Pharma Board of Directors
19 Aug 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Raises $75M for Glaucoma Drug Delivery Platform
02 Jun 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Shows 18-Month Data on IOL Drug Delivery Platform
24 Apr 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Names Chetan Pujara Chief R&D Officer
27 Mar 2025 //
GLOBENEWSWIRE
SpyGlass Completes Enrollment in Glaucoma Drug Delivery Study
19 Nov 2024 //
GLOBENEWSWIRE
SpyGlass Pharma Presents 18-Month Data On Drug Delivery Platform
17 Oct 2024 //
GLOBENEWSWIRE
SpyGlass Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform
02 Apr 2024 //
GLOBENEWSWIRE
SpyGlass Strengthens Leadership to Advance Intraocular Drug Delivery Platform
05 Dec 2023 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.